Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Healios KK Ord Shs HLOSF

HEALIOS K.K. is a Japan-based company mainly engaged in research and development of pharmaceutical products. The Company has compound pharmaceutical products line and induced pluripotent stem cell (iPSC) regenerative medicine product line. The compound pharmaceutical product line contains HLM0021, HLM0022 and HLM0023. The products are ophthalmological surgery adjuvants, mainly contain brilliant... see more

PINL:HLOSF - Post Discussion

Healios KK Ord Shs > New N43-101 is 172% than 2008's
View:
Post by ama21968 on Nov 04, 2010 9:08am

New N43-101 is 172% than 2008's

GLTA
Comment by cuebid201 on Nov 04, 2010 9:42am
So why is there no movement in SP. The company value has just increased significantly!Any ideas?Cue
Comment by sweenby on Nov 04, 2010 10:16am
Ama explained it a few posts back. glta
Comment by ama21968 on Nov 04, 2010 10:33pm
Based on New N43-101: Cold & Lost  ------------- only  Indicated  and  open pit  # Copper 33.8 Million lbs;       ---- 33.8  * 2 $/lb = $ 66.8 Million  Zinc: 86.8 Million lbs ;           ----- 86.8 * 0.75$/lb =$ 65.1 MillionGold 28726 Ozs;     ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities